Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grifols Therapeutics Llc

Clinical trials sponsored by Grifols Therapeutics Llc, explained in plain language.

Now part of Grifols, S.A. GRFS NASDAQ

US subsidiary of Grifols, a global plasma-derived medicines company.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 3 Completed 1

New shot method for Alpha-1 lung disease shows promise in early trial

Disease control Completed

This study tested a new way to give Alpha-1 protein therapy by injecting it under the skin instead of into a vein. Seventeen adults with Alpha-1 Antitrypsin Deficiency received either a low or high dose weekly for eight weeks. The main goal was to check safety and how the drug mo…

Phase: PHASE1, PHASE2 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC